Pregled bibliografske jedinice broj: 1024528
Phenylboronic Acids Probing Molecular Recognition against Class A and Class C β-lactamases
Phenylboronic Acids Probing Molecular Recognition against Class A and Class C β-lactamases // Antibiotics, 8 (2019), 4; 171-171 doi:.org/10.3390/antibiotics8040171 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1024528 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Phenylboronic Acids Probing Molecular Recognition against Class A and Class C β-lactamases
Autori
Linciano, Pasquale ; Vicario, Mattia ; Kekez, Ivana ; Bellio, Pierangelo ; Celenza, Giuseppe ; Martin-Blecua, Isabel ; Blazquez, Jesus ; Cendron, Laura ; Tondi, Donatella
Izvornik
Antibiotics (2079-6382) 8
(2019), 4;
171-171
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Serine β-lactamases ; carbapenemases ; KPC-2 Klebsiella pneumoniae ; GES-5 Guyana extended-spectrum-lactamase ; boronic acid ; enzyme inhibitors ; X-ray crystallography ; synergism
Sažetak
Worldwide dissemination of pathogens resistant to almost all available antibiotics represent a real problem preventing efficient treatment of infectious diseases. Among antimicrobial used in therapy, β-lactam antibiotics represent 40% thus playing a crucial role in the management of infections treatment. We report a small series of phenylboronic acids derivatives (BAs) active against class A carbapenemases KPC-2 and GES-5, and class C cephalosporinases AmpC. The inhibitory profile of our BAs against class A and C was investigated by means of molecular docking, enzyme kinetics and X-ray crystallography. We were interested in the mechanism of recognition among class A and class C to direct the design of broad serine β-Lactamases (SBLs) inhibitors. Molecular modeling calculations vs GES-5 and crystallographic studies vs AmpC reasoned, respectively, the ortho derivative 2 and the meta derivative 3 binding affinity. The ability of our BAs to protect β-lactams from BLs hydrolysis was determined in biological assays conducted against clinical strains: Fractional inhibitory concentration index (FICI) tests confirmed their ability to be synergic with β-lactams thus restoring susceptibility to meropenem. Considering the obtained results and the lack of cytotoxicity, our derivatives represent validated probe for the design of SBLs inhibitors.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Emerging Sources Citation Index (ESCI)
- Scopus